Search results
Results from the WOW.Com Content Network
Nabiximols (brand name Sativex), an oromucosal spray made of a complex botanical mixture containing cannabidiol (CBD), delta-9-tetrahydrocannabinol (THC), and additional cannabinoid and non-cannabinoid constituents from cannabis sativa plants, was approved by Health Canada in 2005, to treat central neuropathic pain in multiple sclerosis, and in ...
Cannabinol (CBN) is a mildly psychoactive phytocannabinoid that acts as a low affinity partial agonist at both CB 1 and CB 2 receptors. This activity at CB 1 and CB 2 receptors constitutes interaction of CBN with the endocannabinoid system (ECS).
The aromatic terpenoids begin to vaporize at 126.0 °C (258.8 °F), but the more bioactive tetrahydrocannabinol (THC), and other cannabinoids also found in cannabis (often legally sold as cannabinoid isolates) like cannabidiol (CBD), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), do not vaporize until near their respective boiling ...
Cannabis plants can exhibit wide variation in the quantity and type of cannabinoids they produce. The mixture of cannabinoids produced by a plant is known as the plant's cannabinoid profile. Selective breeding has been used to control the genetics of plants and modify the cannabinoid profile.
Cannabis and cannabis resin are classified as a Schedule I drug under the Single Convention treaty, meaning that medical use is considered "indispensible for the relief of pain and suffering" but that it is considered to be an addictive medication with risks of abuse. [128]
Female cannabis plants not only contain dronabinol but at least 113 other cannabinoids, [35] including cannabidiol (CBD), thought to be the major anticonvulsant that helps people with multiple sclerosis; [36] and cannabichromene (CBC), an anti-inflammatory which may contribute to the pain-killing effect of cannabis.
The phrase entourage effect was introduced in 1999. [9] [10] While originally identified as a novel method of endocannabinoid regulation by which multiple endogenous chemical species display a cooperative effect in eliciting a cellular response, the term has evolved to describe the polypharmacy effects of combined cannabis phytochemicals or whole plant extracts. [11]
[1] [2] Cannabidiol (CBD), a naturally occurring cannabinoid and a non-competitive CB 1 /CB 2 receptor antagonist, as well as Δ 9-tetrahydrocannabivarin (THCV), a naturally occurring cannabinoid, modulate the effects of THC via direct blockade of cannabinoid CB 1 receptors, thus behaving like first-generation CB 1 receptor inverse agonists ...